The Impact Of Art On Wellbeing In Autoimmune Disease PDF Print E-mail
Tuesday, 25 October 2011 09:11
taken from http://www.flickr.com/photos/georgiap/2230846846/ via creative commonsAn innovative Newcastle research project is measuring the impact of creating art on the symptoms and overall wellbeing of people living with an autoimmune illness.

A team at the University of Newcastle, in conjunction with the Autoimmune Resource and Research Centre at John Hunter Hospital, is working with participants with a range of autoimmune illnesses including Lupus, Scleroderma, Rheumatoid Arthritis and Sjögren's syndrome. Dr Kathryn Grushka from the University said the team was monitoring improvements to participants’ sense of wellbeing and measureable indicators of health, particularly levels of stress.

“Stress is a major flare factor for autoimmune illnesses. We are testing levels of the stress hormone cortisol by taking saliva samples before and after artmaking workshops,” Dr Grushka said.

Participants’ quality of life and functionality is being measured by reviewing digital and written diaries and through standard health assessments, such as testing mobility, blood pressure and heart rate.

The study consists of artists, non-artists and those without an autoimmune illness, with all participants asked to produce artworks based on personal experiences. The results are due to be published in early 2012.

Work created through the project will be displayed in the halls of John Hunter Hospital from Tuesday 4 October, Lupus awareness month, until January 2012 as part of Hunter New England Health’s ‘Arts for Health Program’.

 
More articles :

» New Detection Tools for Autoimmune Disease

More than 50 million people suffer from at least one autoimmune disease, and that number is expected to grow as the baby boomers creep into their sixties and beyond; autoimmunity is more prevalent in an aging population. The laboratory's role is...

» Rheumatic Autoimmune Diseases: A Local Perspective

Arguably one of the more exciting presentations delivered at the recently concluded , local Rheumatologist Dr. Haramnauth Dyaanand of the Gulf View Medical Centre, delved excitedly into the local context for autoimmune diseases. Starting off largely...

» Courts Makes A Contribution To The Scleroderma Care Foundation

(Unicomer Trinidad Limited) graciously contributed on Firday, three Juicers to the . In a statement by Foundation Vice-President, , "Juicing fresh fruits and vegetables is the best way to obtain maximum nutrition. When someone finds themselves...

» Researchers Identify Core Genetic Switch As A Viable Target For New Scleroderma Treatments

Scleroderma is a rare, autoimmune disease. Often fatal, it causes the fibrosis or thickening of the connective tissue which support the skin and other vital organs within the body, through the overproduction of . The disease currently lacks a cure...

» Cell Therapy Yields Promising Results For Scleroderma Treatment

Cytori Therapeutics, Inc. provided preliminary data from a study evaluating a potential treatment for Scleroderma based on the company's cell therapy. The investigator-funded, open-label, pilot study is being conducted on patients with Cutaneous...

» Blocking TGFβ via Inhibition of the αvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease

Tamiko R. Katsumoto, Shelia M. Violette, and Dean SheppardReceived 27 May 2011; Accepted 15 August 2011Interstitial lung disease (ILD) is a commonly encountered complication of systemic sclerosis (SSc) and accounts for a significant proportion of...